Navigation Links
Schizophrenia: Diagnosis Is Not Destiny - Conference
Date:4/7/2008

Meeting Brings Clinicians, Legal Experts, Individuals With Schizophrenia and Families Together for a Comprehensive and Hopeful Look at a Difficult Illness

WASHINGTON, April 7 /PRNewswire-USNewswire/ -- The process of recovering from severe mental illness is the subject of 'Schizophrenia: Diagnosis is not Destiny,' to be held April 12-13, 2008 at the Georgetown University School of Medicine in Washington, DC. We invite you to contact us to learn more about the conference and to make arrangements to cover the conference for your organization.

Sponsored by the Bowen Center for the Study of the Family (http://www.thebowencenter.org) a Washington DC based educational, clinical, and research non-profit organization which was established in 1975, the conference brings together speakers with a broad spectrum of clinical, theoretical, legal, and personal experience to take an interdisciplinary look at schizophrenia. Advances in understanding the brain and the effects of the stress response, growing awareness of the value of systems biology, and the understanding of human relationships provided by Bowen theory will be examined to place schizophrenia within a biospychosocial context.

Speakers include Elyn R. Saks, JD, a law professor and PhD candidate who is the author of a powerful book on her experiences living with schizophrenia. Her book, The Center Cannot Hold, is one of Time Magazines Top 10 Non-Fiction books of 2007 and has been featured in a number of articles, including the current issue New York Review of Books. Other speakers are Esther Sternberg, MD, Chief, Section on Neuroendocrine Immunology and Behavior, NIMH, Michael Lumpkin, PhD a Professor in the Department of Physiology and Biophysics at Georgetown University School of Medicine and Michael E. Kerr, MD, Director of the Bowen Center and in private practice in family psychiatry. The conference also includes interviews wi
'/>"/>

SOURCE BOWEN CENTER FOR THE STUDY OF THE FAMILY
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Increased distance to physician associated with thicker skin cancer at diagnosis
2. Melanoma Diagnosis Often Delayed for Rural Poor
3. Rates of bipolar diagnosis in youth rapidly climbing, treatment patterns similar to adults
4. Research says doctors gender may hinder early diagnosis of heart disease in women
5. What is Being Done to Prevent Misdiagnosis?
6. New research may lead to earlier diagnosis and treatment of primary biliary cirrhosis in families
7. Common misdiagnosis: most women believe they have a yeast infection when they dont
8. Parental surveys boost diagnosis abilities of pediatricians
9. Updated GOLD report presents new understandings in diagnosis, treatment and prevention of COPD
10. European directive will halt use of MRI scans; cancer diagnosis and treatment will suffer
11. Newton-Wellesley Hospital First in Massachusetts to Implement Isabel Diagnosis Decision Support System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/14/2008)... Also debuts TMR,09 campaign, IRVINE, Calif., O...poration (Pink Sheets: CGCP), a global leader of i...nd the market leader of surgical products for,tran...educational symposium,yesterday in conjunction wit...rapeutics (TCT) meeting in Washington, D.C., The ...
(Date:10/14/2008)... more than 500 accounts Company opening new PROMUS...ICK, Mass., Oct. 14 /PRNewswire-FirstCall/ -- Bost...unced estimated U.S. market shares for,September f...liminary data,from Millennium Research Group (MRG)...he healthcare sector., Based on the MRG data, the...
(Date:10/14/2008)... Leading Supplemental Insurance Company Encour... Employee Benefits , Chic...e , a leading provider of supplemental insurance, ...time to review employee benefits and recommends ,V...to help retain employees. These programs can be a ...
(Date:10/14/2008)...ctober 14 /PRNewswire/ -- Researchers at the Insti... started work on a 3.5 year,project to develop a n...hemical vapour deposition) diamond manufactured by...he field of CVD diamond synthesis and its,applicat...uld open up a raft of new,application areas in, fo...
Breaking Medicine News(10 mins):Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4
...als of public health interventions can cost hundre...hers// in this week’s BMJ argue that, if the scien...ne. Randomised controlled trials are usually requ...emented. But in 2003, the BMJ published an article...
...ersity (LLU) shows that adding just a handful of p...xidation of blood lipids// , thus helping reduce t... this positive effect was in part due to the pecan...'Plant foods, including pecans, are rich sources o...
...dial tibial stress syndrome, better known as shin ... conducted// at the University of Messina in Messi...stress syndrome is one of many overuse lower leg i...and accounts for between 13.2% and 17.3% of all ru...
...t has become more common in aged people. Exercise ...h joint // replacement as a treatment for the cond...thritis Care & Research examined whether asking pa...r knee replacement surgery would help in restoring...
Other Medicine News:Health News:Antioxidant-Rich Pecans Protect Against Unhealthy Oxidation in the Body 2Health News:Does Exercise Before Hip Replacement Help? 2
(Date:10/14/2008)... 14 /PRNewswire-USNewswire/ -- The Michael J. Fox,...l of $2 million to five,research teams to speed de...ressed cognitive and mood-related symptoms of Park...oms, which range from problems with,executive func...ute plans),to dementia; depression, apathy and anx...
(Date:10/13/2008)... Stent with Polyzene(R)-F Surface Treatment Maximi...ogenicity, Need for Long-Term,Dual Antiplatelet Th...al investigators at today,s,"Innovative Devices an...nual Transcatheter Cardiovascular Therapeutics (TC...scular Research Foundation, presented,12-month fol...
(Date:10/13/2008)...s., Oct. 13 /- Facet Solutions, Inc. ...p on 20 patients from its US,IDE Pilot Study. The ...y,Index (ODI) scores, and an 80% reduction in Visu...eoff Pardo, President & CEO for Facet Solutions,a...s, which thus far not,only demonstrate significant...
(Date:10/10/2008)... MENLO PARK, Calif., Oct. 10 /PRNewswire-FirstCall...that it plans to present,long-term follow-up data ...,week at the Cardiovascular Research Foundation,s ...r Therapeutics (TCT) meeting in Washington, DC.,Th...esigned to investigate,the safety and efficacy of ...
Breaking Medicine Technology:Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinson's Disease 2Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinson's Disease 3Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinson's Disease 412-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 212-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 312-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 4XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2GSA Selects Cascades Technologies Inc 28CTi 29 to Support USA gov 2431 1GSA Selects Cascades Technologies Inc 28CTi 29 to Support USA gov 2431 2FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 1FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 2FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 3FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 4FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 5Kiwa Bio Tech Products Group Holds a Fertilizer Products Exhibition in Hebei 2427 1Kiwa Bio Tech Products Group Holds a Fertilizer Products Exhibition in Hebei 2427 2Kiwa Bio Tech Products Group Holds a Fertilizer Products Exhibition in Hebei 2427 3Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder 1132 1Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder 1132 2Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder 1132 3Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder 1132 4
...Mullerian Inhibiting Substance (MIS), also known a...glycoprotein dimer composed of two 72 kDa monomers...to the transforming growth factor-? (TGF-?) superf... and activin glycoproteins (2). All members of thi...
The STA Compact CT is a completely automated, benchtop hemostasis analyzer capable of performing clotting assays in random access mode. The system's unique method of sample management offers high thr
...Alpha Fetoprotein (AFP) is a 68 kDa protein, which...tal liver and yolk sac [1]. Human fetal serum AFP...n rates reach 19-26 g/min during mid-gestation (14...es of total fetal AFP continue to increase after m...
Compensating for movement is critical to weighing patients in wheelchairs. Thats why this scale has the exclusive technology to do just that. Extremely durable, with state-of-the-art technology, thes
Medicine Products: